Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

  • Published on: March 15, 2021
  • News
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding…

Whole-genome sequencing and health insurance

  • Published on: February 27, 2021
  • Article
By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there…

Industry Voices – Whole-genome sequencing ultimately benefits payers

  • Published on: February 8, 2021
  • Article
By Daryl Spinner, PhD, MBA When solving a problem, taking a step back and looking at the big picture is…

Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market

  • Published on: January 26, 2021
  • News
January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®…

Ethics in Whole Genome Sequencing

  • Published on: January 20, 2021
  • Article
By Toni Lewis The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or…